Laboratory bacterial culture must be performed to confirm MRSA. Since that is too time-consuming in an acute clinical situation, a physician must make a "best guess".
Methicillin
It depends. Some bacteria, like Staphylococcus aureus, have become resistant to penicillin G. Not all species of Staphylococcus are resistant. Even some strains of Staphylococcus aureus are still susceptible to penicillin G.
It is usually called MRSA: Methicillin-Resistant Staphylococcus Aureus. Methycillin is a version of penicillin that was developed to attack penicillin-resistant bacteria. MRSA can sometimes be treated with other common antibiotics like tetracyclines, e.g. doxycycline.
Penicillin does still work, just not as well. This is because the few germs that can survive the antibiotic will then pass on that capabaility to their progeny; the basics of genetics in action. This means that later generations of the same bacteria need more to kill them or, even worse, are entirely immune to the effect of penicillin. Some strains of bacteria have evolved to the point that they are not only unaffected by penicillin itself, but all drugs similar to penicillin (beta-lactams). One such strain is MRSA (methicillin-resistant Staphylococcus aureus).
Aureus is the specific name.
MRSA is an infection generally associated with hospitals. The abbreviation stands for Methicillin-resistant Staphylococcus aureus. Staphylococcus aureus is the most common of the staphylococcus infections and this particular strain is very serious because it has developed a resistance to all our usual forms of treatment,a nd to our most effective one, Methicillin... a form of penicillin.
Mutant isolation refers to the process of selecting out individual organisms (plant, animal, or microbial) depending upon genetic mutations. For example, staphylococcus aureus, a bacterium, is normally susceptible to a penicillin-derivative called methicillin. If you take a culture of s. aureus growing in a liquid medium, and slowly started adding increasing doses of methicillin, you will gradually kill off the normal s. aureus and leave behind those which have mutated in such a way as to be resistant to the antibiotic.
Pierre Alain Gilbert Domingue has written: 'Influence of sub-inhibitory concentrations of penicillin G on surface properties of iron-deprived staphylococcus aureus NCTC 6571'
Auromycin is a broad-spectrum antibiotic. It main use is for the treatment of penicillin-resistant bacterial infections, such as pneumonia, sepsis, and Staphylococcus aureus. The treatment can also cure typhus, pneumonia and amoebic dysentery.
Paradoxurus aureus was created in 1822.
Fusigobius aureus was created in 1997.
Galt Aureus was created in 2005.